Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Ozone therapy might improve cancer treatment and reduce its side effects.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Finasteride does not prevent bladder cancer.

Targeting the Smoothened receptor shows promise for treating certain cancers.

The reviewers suggest clarifying the abstract, adding background on inflammation's effect on stem cells and cancer, discussing immune cells' role in tumors, and considering inflammation's potential to reduce cancer growth.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

The revised manuscript on how inflammation affects cancer stem cells was accepted after addressing issues with clarity and detail.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

The revised study on how inflammation affects cancer stem cells was accepted after improving clarity and structure.

Onions may help reduce cancer risk and obesity-related issues.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The reviewers suggest major revisions for clarity and inclusion of recent findings on inflammation's role in cancer.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.